Consumer health advertising is driving many employees to take action on GLP-1s. But without guidance, those decisions could be risky, new research finds.
GLP-1 cost pressure is now a talent retention issue. A new study found that 29% of employees would switch jobs for coverage, but these drugs aren't cheap for employers.
Rather than defaulting to higher employee contributions or reduced coverage, many employers are seeking structural, data-driven strategies that address cost drivers at their source.
